HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q2 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $740,000 | +85.0% | 28,000 | +36.6% | 0.00% | +50.0% |
| Q4 2018 | $400,000 | +58.7% | 20,500 | +58.9% | 0.00% | +100.0% |
| Q3 2018 | $252,000 | +41.6% | 12,900 | +19.4% | 0.00% | 0.0% |
| Q2 2018 | $178,000 | +102.3% | 10,800 | +74.2% | 0.00% | – |
| Q1 2018 | $88,000 | -2.2% | 6,200 | 0.0% | 0.00% | – |
| Q4 2017 | $90,000 | -15.1% | 6,200 | -31.1% | 0.00% | – |
| Q2 2017 | $106,000 | -20.3% | 9,000 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $133,000 | -26.5% | 9,000 | -19.6% | 0.00% | 0.0% |
| Q4 2016 | $181,000 | -54.2% | 11,200 | -48.6% | 0.00% | -50.0% |
| Q3 2016 | $395,000 | +14.5% | 21,800 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $345,000 | -79.5% | 21,000 | -75.3% | 0.00% | -75.0% |
| Q3 2015 | $1,684,000 | +207.3% | 85,000 | +90.6% | 0.01% | +700.0% |
| Q3 2014 | $548,000 | – | 44,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $37,065,000 | 56.74% |
| Broadfin Capital, LLC | 8,131,310 | $176,205,000 | 10.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,684,801 | $253,210,000 | 10.26% |
| ATERNALIS CAPITAL LLC | 410,000 | $8,885,000 | 5.84% |
| JW Asset Management, LLC | 673,075 | $14,586,000 | 5.44% |
| NEXTHERA CAPITAL LP | 144,000 | $3,120,000 | 4.43% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 739,485 | $16,025,000 | 2.77% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,519,955 | $54,607,000 | 2.66% |
| Ratan Capital Management LP | 500,000 | $10,835,000 | 2.39% |
| TIGER MANAGEMENT L.L.C. | 823,577 | $17,847,000 | 2.30% |